{"id":"https://openalex.org/W4285589654","doi":"https://doi.org/10.2217/fon-2022-0421","title":"Patient preferences for treatment in relapsed/refractory diffuse large B-cell lymphoma: a discrete choice experiment","display_name":"Patient preferences for treatment in relapsed/refractory diffuse large B-cell lymphoma: a discrete choice experiment","publication_year":2022,"publication_date":"2022-07-15","ids":{"openalex":"https://openalex.org/W4285589654","doi":"https://doi.org/10.2217/fon-2022-0421","pmid":"https://pubmed.ncbi.nlm.nih.gov/35837970"},"language":"en","primary_location":{"id":"doi:10.2217/fon-2022-0421","doi":"https://doi.org/10.2217/fon-2022-0421","is_oa":true,"landing_page_url":"https://doi.org/10.2217/fon-2022-0421","pdf_url":"https://www.tandfonline.com/doi/pdf/10.2217/fon-2022-0421?needAccess=true","source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.tandfonline.com/doi/pdf/10.2217/fon-2022-0421?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012273590","display_name":"Kelly Birch","orcid":"https://orcid.org/0000-0003-3538-0712","observed_orcids":["https://orcid.org/0000-0003-3538-0712"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Kelly Birch","raw_affiliation_strings":["PRECISIONheor,\r6550 Rock Spring Dr #155,\rBethesda,\rMD 20817,\rUSA"],"raw_orcid":"https://orcid.org/0000-0003-3538-0712","affiliations":[{"raw_affiliation_string":"PRECISIONheor,\r6550 Rock Spring Dr #155,\rBethesda,\rMD 20817,\rUSA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027316831","display_name":"Julia Thornton Snider","orcid":"https://orcid.org/0000-0003-0017-4863","observed_orcids":["https://orcid.org/0000-0003-0017-4863"]},"institutions":[{"id":"https://openalex.org/I4405261804","display_name":"Kite Pharma (United States)","ror":"https://ror.org/05waa9105","country_code":"US","type":"company","lineage":["https://openalex.org/I4405261804"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julia T Snider","raw_affiliation_strings":["Kite Pharmaceuticals, 2400 Broadway, Santa Monica, CA 90404, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kite Pharmaceuticals, 2400 Broadway, Santa Monica, CA 90404, USA","institution_ids":["https://openalex.org/I4405261804"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048850106","display_name":"Kevin Chiu","orcid":"https://orcid.org/0000-0003-2584-3736","observed_orcids":["https://orcid.org/0000-0003-2584-3736"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin Chiu","raw_affiliation_strings":["OnPoint Analytics,\r200 Powell St #860,\rEmeryville,\rCA 94608,\rUSA"],"raw_orcid":"https://orcid.org/0000-0003-2584-3736","affiliations":[{"raw_affiliation_string":"OnPoint Analytics,\r200 Powell St #860,\rEmeryville,\rCA 94608,\rUSA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"James Baumgardner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James Baumgardner","raw_affiliation_strings":["PRECISIONheor, 6550 Rock Spring Dr #155, Bethesda, MD 20817, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PRECISIONheor, 6550 Rock Spring Dr #155, Bethesda, MD 20817, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034329124","display_name":"Sally West Wade","orcid":"https://orcid.org/0000-0003-4726-7995","observed_orcids":["https://orcid.org/0000-0003-4726-7995"]},"institutions":[{"id":"https://openalex.org/I4405261804","display_name":"Kite Pharma (United States)","ror":"https://ror.org/05waa9105","country_code":"US","type":"company","lineage":["https://openalex.org/I4405261804"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sally W Wade","raw_affiliation_strings":["Kite Pharmaceuticals,\r2400 Broadway,\rSanta Monica,\rCA 90404,\rUSA","Wade Outcomes Research & Consulting,\r136 U Street,\rSalt Lake City,\rUT 84103,\rUSA","Kite Pharmaceuticals, 2400 Broadway, Santa Monica, CA 90404, USAWade Outcomes Research & Consulting, 136 U Street, Salt Lake City, UT 84103, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kite Pharmaceuticals,\r2400 Broadway,\rSanta Monica,\rCA 90404,\rUSA","institution_ids":["https://openalex.org/I4405261804"]},{"raw_affiliation_string":"Wade Outcomes Research & Consulting,\r136 U Street,\rSalt Lake City,\rUT 84103,\rUSA","institution_ids":[]},{"raw_affiliation_string":"Kite Pharmaceuticals, 2400 Broadway, Santa Monica, CA 90404, USAWade Outcomes Research & Consulting, 136 U Street, Salt Lake City, UT 84103, USA","institution_ids":["https://openalex.org/I4405261804"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021595775","display_name":"Gunjan L. Shah","orcid":"https://orcid.org/0000-0002-9977-0456","observed_orcids":["https://orcid.org/0000-0002-9977-0456"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gunjan Shah","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5012273590"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0091,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.88931393,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"18","issue":"25","first_page":"2791","last_page":"2804"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10841","display_name":"Economic and Environmental Valuation","score":0.6904000043869019,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10841","display_name":"Economic and Environmental Valuation","score":0.6904000043869019,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.1160999983549118,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0738999992609024,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9879999756813049},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/patient-preferences","display_name":"patient preferences","score":0.8309999704360962},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8479999899864197},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9800000190734863},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8130000233650208},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.8199999928474426},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.9399999976158142},{"id":"https://openalex.org/keywords/infection-risk","display_name":"infection risk","score":0.8040000200271606},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6420000195503235}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8953421115875244},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.7238616943359375},{"id":"https://openalex.org/C2780850621","wikidata":"https://www.wikidata.org/wiki/Q3961647","display_name":"Cytokine release syndrome","level":5,"score":0.6470685005187988},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6396226286888123},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.5659658312797546},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5275886654853821},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5181335210800171},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.4964757561683655},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49413707852363586},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.4476920962333679},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.20068204402923584},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.17423802614212036},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016403","descriptor_name":"Lymphoma, Large B-Cell, Diffuse","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D018941","descriptor_name":"Antigens, CD19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057240","descriptor_name":"Patient Preference","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2217/fon-2022-0421","doi":"https://doi.org/10.2217/fon-2022-0421","is_oa":true,"landing_page_url":"https://doi.org/10.2217/fon-2022-0421","pdf_url":"https://www.tandfonline.com/doi/pdf/10.2217/fon-2022-0421?needAccess=true","source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},{"id":"pmid:35837970","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35837970","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future oncology (London, England)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.2217/fon-2022-0421","doi":"https://doi.org/10.2217/fon-2022-0421","is_oa":true,"landing_page_url":"https://doi.org/10.2217/fon-2022-0421","pdf_url":"https://www.tandfonline.com/doi/pdf/10.2217/fon-2022-0421?needAccess=true","source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4285589654.pdf","grobid_xml":"https://content.openalex.org/works/W4285589654.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1999130958","https://openalex.org/W2019734962","https://openalex.org/W2048709304","https://openalex.org/W2065778093","https://openalex.org/W2122707212","https://openalex.org/W2136060045","https://openalex.org/W2150587745","https://openalex.org/W2152081677","https://openalex.org/W2159936838","https://openalex.org/W2367707061","https://openalex.org/W2565561569","https://openalex.org/W2773804840","https://openalex.org/W2893050608","https://openalex.org/W2903062212","https://openalex.org/W2929766235","https://openalex.org/W2944222080","https://openalex.org/W2986232810","https://openalex.org/W2991696549","https://openalex.org/W2994541683","https://openalex.org/W3032751161","https://openalex.org/W3043730230","https://openalex.org/W3081687748","https://openalex.org/W3127054864","https://openalex.org/W3154997741","https://openalex.org/W3165864905","https://openalex.org/W3203316891","https://openalex.org/W3212349863","https://openalex.org/W3212944538","https://openalex.org/W3215512067","https://openalex.org/W4200014243","https://openalex.org/W4200201081","https://openalex.org/W4214859401","https://openalex.org/W4221044986","https://openalex.org/W4248608538"],"related_works":["https://openalex.org/W4281828205","https://openalex.org/W3203316891","https://openalex.org/W7153047710","https://openalex.org/W3025466634","https://openalex.org/W4415406077","https://openalex.org/W3043730230","https://openalex.org/W4411907834","https://openalex.org/W2765156323","https://openalex.org/W4399553540","https://openalex.org/W4380149174"],"abstract_inverted_index":{"Aim:":[0],"We":[1],"quantified":[2],"patient":[3],"preferences":[4],"for":[5,55],"second-line":[6],"diffuse":[7,32],"large":[8,33],"B-cell":[9,34],"lymphoma":[10,35],"therapies,":[11],"including":[12],"attributes":[13,51],"of":[14,79,91,110],"chimeric":[15],"antigen":[16],"receptor":[17],"(CAR)":[18],"T-cell":[19],"therapy.":[20],"Materials":[21],"&":[22],"methods:":[23],"Using":[24],"a":[25,99],"discrete":[26],"choice":[27],"experiment,":[28],"we":[29],"surveyed":[30],"224":[31],"patients":[36],"from":[37],"the":[38,77],"USA":[39],"and":[40,68,94,118],"Europe.":[41],"Patients":[42,115],"chose":[43],"between":[44],"two":[45],"treatment":[46],"options":[47],"defined":[48],"by":[49,88],"six":[50],"with":[52],"predefined":[53],"levels":[54],"overall":[56],"survival,":[57],"adverse":[58,112,122],"events":[59],"(severe":[60],"cytokine-release":[61,92],"syndrome,":[62],"severe":[63,66],"neurological":[64,95],"toxicities,":[65],"infection)":[67],"time":[69],"to":[70,72,85,107,125],"return":[71],"pre-treatment":[73],"functioning.":[74],"Results:":[75],"Increasing":[76],"probability":[78,106],"1-year":[80,104],"survival":[81,105,117,127],"was":[82],"most":[83],"important":[84],"patients,":[86],"followed":[87],"avoiding":[89],"risks":[90,109,124],"syndrome":[93],"toxicities.":[96],"Respondents":[97],"required":[98],"13\u201314":[100],"percentage":[101],"point":[102],"increased":[103],"accept":[108,120],"treatment-associated":[111],"events.":[113],"Conclusion:":[114],"prioritize":[116],"will":[119],"certain":[121],"event":[123],"gain":[126],"improvements.":[128]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-07-16T00:00:00"}